First Time Loading...

BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 2.82 EUR 0.71%
Updated: May 3, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

66.5m
-6%
Assets
Growth Rates:
1 Year
-12%
3 Years
-1%
5 Years
+2%
7 Years
+45%
10 Years
-
46m
-6%
Liabilities
Growth Rates:
1 Year
+5%
3 Years
+4%
5 Years
+9%
7 Years
+115%
10 Years
-
20.5m
-6%
Equity
Growth Rates:
1 Year
-35%
3 Years
-11%
5 Years
-10%
7 Years
-16%
10 Years
-

Balance Sheet Decomposition
BRAIN Biotech AG

66.5m
Assets
46m
Liabilities
66.5m
Assets
46m
Liabilities
Current Assets 22.1m
Other Current Assets 22.1m
Non-Current Assets 44.4m
Other Non-Current Assets 44.4m
Current Liabilities 13.4m
Other Current Liabilities 13.4m
Non-Current Liabilities 32.6m
Other Non-Current Liabilities 32.6m

Balance Sheet
BRAIN Biotech AG

Rotate your device to view
Balance Sheet
Currency: EUR
Sep-2014 Sep-2015 Sep-2016 Sep-2017 Sep-2018 Sep-2019 Sep-2020 Sep-2021 Sep-2022 Sep-2023
Assets
Cash & Cash Equivalents
4
3
8
39
26
15
19
25
8
5
Cash Equivalents
4
3
8
39
26
15
19
25
8
5
Short-Term Investments
0
0
10
0
0
0
0
0
0
0
Total Receivables
3
4
6
7
7
7
7
7
11
10
Accounts Receivables
2
3
3
4
5
6
6
6
7
9
Other Receivables
0
1
3
3
1
1
1
0
4
1
Inventory
5
7
7
7
8
8
7
7
10
10
Other Current Assets
0
1
0
0
1
1
1
0
1
0
Total Current Assets
12
15
32
54
41
31
33
39
30
25
PP&E Net
7
7
7
8
12
17
24
24
29
29
PP&E Gross
0
7
7
8
12
17
24
24
29
29
Accumulated Depreciation
0
6
6
7
8
9
10
13
14
17
Intangible Assets
6
5
5
4
13
11
9
9
10
9
Goodwill
0
3
3
3
6
5
4
5
7
7
Note Receivable
0
0
0
0
0
1
0
0
0
0
Long-Term Investments
0
0
0
0
2
1
1
1
2
1
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Other Assets
0
3
3
3
6
5
4
5
7
7
Total Assets
25
N/A
30
+20%
48
+56%
69
+44%
74
+9%
66
-11%
72
+9%
78
+8%
78
+0%
71
-9%
Liabilities
Accounts Payable
1
3
3
2
3
4
3
4
7
6
Accrued Liabilities
0
0
0
0
0
1
3
2
2
3
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
2
2
3
2
2
2
2
2
3
4
Other Current Liabilities
2
3
4
4
6
7
4
3
10
5
Total Current Liabilities
5
8
10
8
11
15
12
11
21
17
Long-Term Debt
7
14
6
8
25
5
11
9
8
18
Deferred Income Tax
1
1
1
1
3
3
2
3
3
4
Minority Interest
0
0
0
0
5
5
5
3
5
1
Other Liabilities
0
1
3
3
7
23
21
13
11
9
Total Liabilities
13
N/A
25
+88%
21
-17%
21
+2%
51
+139%
51
0%
51
+1%
39
-24%
48
+24%
49
+2%
Equity
Common Stock
13
13
16
18
18
18
20
22
22
22
Retained Earnings
1
7
10
29
5
68
77
80
85
94
Additional Paid In Capital
0
0
0
0
0
65
78
96
93
93
Other Equity
0
0
0
0
0
0
0
1
0
1
Total Equity
12
N/A
5
-55%
27
+389%
47
+77%
24
-50%
15
-35%
21
+36%
39
+87%
30
-24%
22
-27%
Total Liabilities & Equity
25
N/A
30
+20%
48
+56%
69
+44%
74
+9%
66
-11%
72
+9%
78
+8%
78
+0%
71
-9%
Shares Outstanding
Common Shares Outstanding
13
13
16
18
18
18
20
22
22
22

See Also

Summary
BNN intrinsic value, competitors valuation, and company profile.
DCF Valuation
BNN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BNN stock valuation using valuation multiples.
Wall Street Estimates
BNN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BNN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.